175 related articles for article (PubMed ID: 8687314)
1. Clinical management of fungal infections.
Speed B
Aust Fam Physician; 1996 Jun; 25(6):903-5. PubMed ID: 8687314
[TBL] [Abstract][Full Text] [Related]
2. Recent trends in antifungal therapy: focus on systemic mycoses.
Ray A; Anand S
Indian J Chest Dis Allied Sci; 2000; 42(4):357-66. PubMed ID: 15597685
[TBL] [Abstract][Full Text] [Related]
3. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and management of fungal infections in immunocompromised patients.
Venkatesan P; Perfect JR; Myers SA
Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
[TBL] [Abstract][Full Text] [Related]
5. Alternaria infections: laboratory diagnosis and relevant clinical features.
Pastor FJ; Guarro J
Clin Microbiol Infect; 2008 Aug; 14(8):734-46. PubMed ID: 18727797
[TBL] [Abstract][Full Text] [Related]
6. Current and future therapy of invasive fungal infections.
Andriole VT
Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349
[TBL] [Abstract][Full Text] [Related]
7. Fungal infections: guidelines for reporting. PHLS Mycology Committee.
Evans EG; Farrell ID; Gross RJ; Hay RJ; Midgley G; Reuther JW; Richardson MD; Roberts DT; Warnock DW; Warren RE; Wingfield HJ
Commun Dis Rep CDR Rev; 1996 Apr; 6(5):R75. PubMed ID: 8935422
[No Abstract] [Full Text] [Related]
8. Changing strategies for the management of invasive fungal infections.
Rapp RP
Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
[TBL] [Abstract][Full Text] [Related]
9. [Fungal infections in primary care].
Schaffner A
Praxis (Bern 1994); 1996 Oct; 85(40):1236-9. PubMed ID: 8966412
[TBL] [Abstract][Full Text] [Related]
10. Superficial fungal infections in children and adolescents.
Rudy SJ
Nurse Pract Forum; 1999 Jun; 10(2):56-66. PubMed ID: 10542582
[TBL] [Abstract][Full Text] [Related]
11. Therapy of common superficial fungal infections.
Huang DB; Ostrosky-Zeichner L; Wu JJ; Pang KR; Tyring SK
Dermatol Ther; 2004; 17(6):517-22. PubMed ID: 15571501
[TBL] [Abstract][Full Text] [Related]
12. Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B.
Bellmann R; Cleary JD; Sterba J
Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-8. PubMed ID: 19537331
[TBL] [Abstract][Full Text] [Related]
13. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
Shao PL; Huang LM; Hsueh PR
J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit.
Devlin RK
Adv Neonatal Care; 2006 Apr; 6(2):68-77; quiz 78-9. PubMed ID: 16618476
[TBL] [Abstract][Full Text] [Related]
16. Improving efficacy of antifungal therapy by polymerase chain reaction-based strategy among febrile patients with neutropenia and cancer.
Lin MT; Lu HC; Chen WL
Clin Infect Dis; 2001 Nov; 33(10):1621-7. PubMed ID: 11595977
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of antifungal agents.
Kaur IP; Kakkar S
Expert Opin Drug Deliv; 2010 Nov; 7(11):1303-27. PubMed ID: 20961206
[TBL] [Abstract][Full Text] [Related]
18. [Systemic fungal infections in immunocompromised patients].
Zupanić-Krmek D; Nemet D
Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
[TBL] [Abstract][Full Text] [Related]
19. Dermatophyte infections.
Hainer BL
Am Fam Physician; 2003 Jan; 67(1):101-8. PubMed ID: 12537173
[TBL] [Abstract][Full Text] [Related]
20. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
De Rosso JQ; Gupta AK
Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
